ES2162000T3 - Lactilaminas y aplicaciones farmaceuticas. - Google Patents

Lactilaminas y aplicaciones farmaceuticas.

Info

Publication number
ES2162000T3
ES2162000T3 ES96420032T ES96420032T ES2162000T3 ES 2162000 T3 ES2162000 T3 ES 2162000T3 ES 96420032 T ES96420032 T ES 96420032T ES 96420032 T ES96420032 T ES 96420032T ES 2162000 T3 ES2162000 T3 ES 2162000T3
Authority
ES
Spain
Prior art keywords
lactilamins
pharmaceutical
applications
salts
lactylamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96420032T
Other languages
English (en)
Inventor
Isabelle Rico-Lattes
Armand Lattes
Alain Caparros
Christiane Andre-Barres
Lionel Godefroy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stepan Europe SAS
Original Assignee
Stepan Europe SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stepan Europe SAS filed Critical Stepan Europe SAS
Application granted granted Critical
Publication of ES2162000T3 publication Critical patent/ES2162000T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A LOS COMPUESTOS CUYA ESTRUCTURAS RESPONDE A LA FORMULA I EN LA QUE - R{SUB,1} REPRESENTA (CH{SUB,2}){SUB,N}-CH{SUB,3} O -(CH{SUB,2}){SUB,N}-COO{SUP,}X{SUP,+}, ESTANDO N COMPRENDIDO ENTRE 5 Y 15, REPRESENTANDO X{SUP,+} UN CATION PARTICULARMENTE ELEGIDO ENTRE H{SUP,+}, NA{SUP,+}, K{SUP,+}, NH{SUB,4+}, LI{SUP,+}, MG{SUP,2+}, Y R{SUB,2} REPRESENTA H O CO-(CH{SUB,2}){SUB,M}-CH{SUB,3}, ESTANDO M COMPRENDIDO ENTRE 5 Y16, CON EXCLUSION DE LOS COMPUESTOS CUYA ESTRUCTURA RESPONDE A LA FORMULA I EN LA QUE R{SUB,1} REPRESENTA -(CH{SUB,2}){SUB,N}-CH{SUB,3} Y R{SUB,2} REPRESENTA H, Y SUS APLICACIONES FARMACEUTICAS, ASI COMO LAS DE LOS COMPUESTAS DE FORMULA I EN LA QUE: R{SUB,1} REPRESENTA (CH{SUB,2}){SUB,N}-CH{SUB,3} Y R{SUB,2} REPRESENTA H, PARTICULARMENTE ANTIVIH.
ES96420032T 1995-01-30 1996-01-30 Lactilaminas y aplicaciones farmaceuticas. Expired - Lifetime ES2162000T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9501296A FR2729959B1 (fr) 1995-01-30 1995-01-30 Lactylamines et applications pharmaceutiques

Publications (1)

Publication Number Publication Date
ES2162000T3 true ES2162000T3 (es) 2001-12-16

Family

ID=9475830

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96420032T Expired - Lifetime ES2162000T3 (es) 1995-01-30 1996-01-30 Lactilaminas y aplicaciones farmaceuticas.

Country Status (5)

Country Link
EP (1) EP0723972B1 (es)
AT (1) ATE203543T1 (es)
DE (1) DE69614006T2 (es)
ES (1) ES2162000T3 (es)
FR (1) FR2729959B1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030063A2 (en) * 1996-02-19 1997-08-21 Coöperatieve Weiproduktenfabriek 'borculo' W.A. Preparation of surface-active compounds based on lactose
FR2888752B1 (fr) * 2005-07-22 2007-10-05 Fabre Pierre Dermo Cosmetique Complexe d'association intermoleculaire d'un transporteur et d'un principe actif
CN101395168B (zh) * 2006-03-01 2011-11-16 日本新药株式会社 半乳糖衍生物、药物载体及医药组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2661413A1 (fr) * 1990-04-26 1991-10-31 Stepan Europe N-alkyllactylamines et leurs procede de preparation.

Also Published As

Publication number Publication date
DE69614006D1 (de) 2001-08-30
FR2729959A1 (fr) 1996-08-02
FR2729959B1 (fr) 1997-03-21
ATE203543T1 (de) 2001-08-15
EP0723972A1 (fr) 1996-07-31
DE69614006T2 (de) 2002-04-18
EP0723972B1 (fr) 2001-07-25

Similar Documents

Publication Publication Date Title
GEP20063799B (en) Tropane derivatives useful in therapy
ATE290015T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
CA2119636A1 (en) Low pH Aqueous Cosmetic Gel Containing Non-Ionic Polyacrylamide Derivatives
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
ATE153853T1 (de) Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph
NO2011018I1 (no) Eribulin og farmasøytisk akseptable salter derav
DK0459666T3 (da) Lægemidler mod impotens
GEP20043162B (en) Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
EP0375628A3 (en) Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment
ATE38991T1 (de) In 2-stellung substituierte 1,3propyledendephosphonat-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
BR9611871A (pt) Diaminopirimidinas composições farmacêuticas contendo as mesmas e seu uso como antibactericidas
DK1189595T3 (da) Ophthalmiske sammensætninger i form af vandige geler
ATE129157T1 (de) Anti-hiv mittel.
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
FR2729959B1 (fr) Lactylamines et applications pharmaceutiques
DE69117303D1 (de) Zusammensetzung mit psyllium
IE40661L (en) Tetracyclic piperidino derivatives
AU614204B2 (en) 16-hydroxymethyl amphotericin b derivatives
ES2193007T1 (es) Formulacion farmaceutica estable que comprende la modificacion ii de torsemida.
ATE203903T1 (de) Delta-aminolävulinsäure enthaltendes arzneimittel
IT1261646B (it) Derivati peptidici ad attivita' citostimolante e citoprotettiva
NZ224726A (en) 1-oxa-2-oxo-3,8-diaza-spiro (4.5 decane derivatives and pharmaceutical compositions
GR3023941T3 (en) Cyclic derivatives of angiopeptin, their preparation and their pharmaceutical compositions.
IT1264546B1 (it) Composizione farmaceutica ad attivita' antiacida in forma di sospensione a base di gel di sucralfato
RU99124649A (ru) Противовирусное средство для наружного применения на основе гиалуроновой кислоты

Legal Events

Date Code Title Description
FA2A Application withdrawn

Effective date: 19970225

FG2A Definitive protection

Ref document number: 723972

Country of ref document: ES